Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/08/20/3136285/0/en/First-PRIZM-Study-Participant-Enrolled-in-Tisento-Therapeutics-Open-Label-Extension-Study-in-MELAS.html

GLOBENEWSWIRE
20 Aug 2025

https://www.globenewswire.com/news-release/2025/01/27/3015457/0/en/First-Participant-Dosed-in-Tisento-Therapeutics-Global-Phase-2b-PRIZM-Study-Evaluating-Zagociguat-for-the-Treatment-of-MELAS.html

GLOBENEWSWIRE
27 Jan 2025

https://www.globenewswire.com/news-release/2023/05/11/2667449/0/en/Cyclerion-Announces-Definitive-Agreement-for-Zagociguat-and-CY3018.html

GLOBENEWSWIRE
11 May 2023